Product News

Pirfenidone Clonmel

By Danielle Norton December 2, 2022 Updated February 20, 2024 1 min read

Pirfenidone Clonmel

Clonmel Healthcare is delighted to announce the launch of Pirfenidone Clonmel 267mg and 801mg film-coated tablets.

Pirfenidone Clonmel is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation Cancel reply

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free